Total Debt
$919K
Net Debt
-$1.02B
Terns Pharmaceuticals, Inc. currently has $919K in total debt. Net debt is -$1.02B after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
TERN • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2025-12-31 | 0.00 | 1.02 | -1.02Net Cash | 1.03 | 0.1% |
| 2025-09-30 | 0.00 | 0.30 | -0.29Net Cash | 0.30 | 0.3% |
| 2025-06-30 | 0.00 | 0.32 | -0.31Net Cash | 0.32 | 0.4% |
| 2025-03-31 | 0.00 | 0.33 | -0.33Net Cash | 0.34 | 0.4% |
| 2024-12-31 | 0.00 | 0.36 | -0.36Net Cash | 0.36 | 0.4% |
| 2024-09-30 | 0.00 | 0.37 | -0.37Net Cash | 0.38 | 0.3% |
| 2024-06-30 | 0.00 | 0.23 | -0.23Net Cash | 0.23 | 0.1% |
| 2024-03-31 | 0.00 | 0.24 | -0.24Net Cash | 0.25 | 0.2% |
| 2023-12-31 | 0.00 | 0.26 | -0.26Net Cash | 0.27 | 0.2% |
| 2023-09-30 | 0.00 | 0.27 | -0.27Net Cash | 0.27 | 0.3% |
| 2023-06-30 | 0.00 | 0.29 | -0.28Net Cash | 0.29 | 0.3% |
| 2023-03-31 | 0.00 | 0.30 | -0.30Net Cash | 0.30 | 0.3% |
| 2022-12-31 | 0.00 | 0.28 | -0.28Net Cash | 0.29 | 0.4% |
| 2022-09-30 | 0.00 | 0.19 | -0.19Net Cash | 0.19 | 0.7% |
| 2022-06-30 | 0.00 | 0.14 | -0.14Net Cash | 0.14 | 1.0% |
| 2022-03-31 | 0.00 | 0.15 | -0.15Net Cash | 0.16 | 1.0% |
| 2021-12-31 | 0.00 | 0.17 | -0.17Net Cash | 0.17 | 0.0% |
| 2021-09-30 | 0.00 | 0.18 | -0.18Net Cash | 0.18 | 0.0% |
| 2021-06-30 | 0.00 | 0.19 | -0.19Net Cash | 0.19 | 0.0% |
| 2021-03-31 | 0.00 | 0.20 | -0.20Net Cash | 0.20 | 0.0% |
| 2020-12-31 | 0.01 | 0.07 | -0.06Net Cash | 0.09 | 14.0% |
| 2020-09-30 | 0.02 | 0.01 | 0.01 | 0.02 | 111.0% |
| 2020-03-31 | 0.00 | 0.02 | -0.02Net Cash | 0.00 | — |
| 2019-12-31 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |